middle.news
How Will MedAdvisor’s US Restructuring Shape Its FY26 Comeback?
9:50am on Thursday 31st of July, 2025 AEST
•
Healthcare Technology
Read Story
How Will MedAdvisor’s US Restructuring Shape Its FY26 Comeback?
9:50am on Thursday 31st of July, 2025 AEST
Key Points
FY25 revenue down 27.9% to $88 million due to US health program delays
Successful $7.7 million capital raise and $35 million ANZ business sale completed
US business restructuring ongoing with a strong $125 million pipeline for FY26
Company now debt-free following ANZ sale proceeds used to repay debt
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MDR
OPEN ARTICLE